| abstract |
The present invention relates to the sex, age and dose effects of desmopressin on reducing nocturnal voiding, increasing the initial period of unobstructed sleep, and / or reducing nocturnal urine output. A method for increasing the initial period of unhindered sleep in a patient requiring an increase in the initial period of unhindered sleep, wherein a dose of 10 μg of orodispersible desmopressin is given before bedtime Administration to the patient, wherein the dose is measured as the free base of desmopressin, and the dose taken over the treatment period provides a method to increase the initial period of undisturbed sleep of the patient. [Selected figure] Figure 1 |